arrow
T

Taichi Isobe

kyushu university
H指数:16
被引数:2,883

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase Ia/Ib trial of the safety and efficacy of mobocertinib in combination with T-DM1 for patients with HER2-mutant solid tumors (WJOG16022M)

Ia/Ib期临床试验,评估mobocertinib联合T-DM1在HER2突变实体瘤患者中的安全性和有效性(WJOG16022M)

2026-03-190
OAAI
Real-World Comparative Study of Atezolizumab-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer

基于阿替利珠单抗的化疗方案在晚期非小细胞肺癌中的真实世界比较研究

2025-11-180
OAAI
Elucidation of the mechanism of carcinogenic transformation of human gastric epithelial cells in atrophic gastritis

阐明萎缩性胃炎中人类胃上皮细胞癌变转化的机制

2025-06-180
PRE
Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer
2024-10-190
OAAI
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan
2023-10-310
OAAI
Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model
2022-06-049
OA
Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells
2022-03-046
OA
Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
2021-10-266
OAAI
Eribulin as a first-line treatment for soft tissue sarcoma patients with contraindications for doxorubicin
2020-12-017
OAAI